Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2005 by National Taiwan University Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00173355
First received: September 12, 2005
Last updated: November 23, 2005
Last verified: August 2005

September 12, 2005
November 23, 2005
June 2005
 
 
 
Complete list of historical versions of study NCT00173355 on ClinicalTrials.gov Archive Site
 
 
 
 
 
Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans
Retrospective Clinical Outcome Study of Pediatric Dermatofibrosarcoma Protuberans: Single Institutional Experience of Twelve Cases From 1977-2002

Retrospective review of clinical outcome of pediatric Dermatofibrosarcoma Protuberans (PDFSP) after active invitation

Soft tissue sarcoma was rarely seen in pediatric patients, and pediatric Dermatofibrosarcoma Protuberans (PDFSP) was even rare. To our knowledge, the largest report constituted of 19 cases (five of them had no follow-up (FU) status) (1). So we proposed this retrospective study based on the cancer registry of our hospital. Twelve cases who were diagnosed as DFSP before age of 18 were identified. But all of them had been lost of FU for at least two years. So we will try to contact these patients and asked them to be back to our clinic for routine surveillance (history taking and physical exam and optional local image/chest xray) and quality of life (QoL) evaluation after pathological review if this clinical study was approved (2)

Observational
Observational Model: Defined Population
Observational Model: Natural History
Time Perspective: Longitudinal
Time Perspective: Retrospective
 
 
 
Soft Tissue Neoplasms
 
 
 

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
12
August 2005
 

Inclusion Criteria:

  • Patients diagnosed as DFSP before age of 18 after pathological review according to the cancer registry of our hospital

Exclusion Criteria:

  • age > 18 at diagnosis
Both
up to 18 Years
No
Contact: Chun-Ru Chien, M.D. 886-2-23123456 ext 2643 stwo@ha.mc.ntu.edu.tw
Contact: Rong-Sen Yang, M.D, Ph.D 886-2-23516478 ext 3958 yang@ha.mc.ntu.edu.tw
Taiwan
 
NCT00173355
9461700618
 
 
National Taiwan University Hospital
 
Study Chair: Rong-Sen Yang, M.D., Ph.D. National Taiwan University Hospital
National Taiwan University Hospital
August 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP